M10.25
Drug-induced gout, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced gout of the hip, classified under ICD-10 code M10.25, is a form of gout that develops as a reaction to certain medications. Gout is a type of inflammatory arthritis characterized by sudden and severe pain, redness, and swelling in the joints. When medications cause this condition, it is specifically referred to as drug-induced gout, and when it affects the hip, the symptoms can significantly impair mobility and quality of life. Recognizing this condition is important for timely management and prevention of joint damage.
Causes & Symptoms
Clinical Causes: Use of medications that increase uric acid levels, such as diuretics (e.g., thiazides and loops) Medication side effects leading to decreased uric acid excretion High doses or prolonged use of certain immunosuppressants or chemotherapy agents Medication interactions that affect kidney function or uric acid metabolism Underlying health conditions exacerbated by medication use, such as kidney impairment
Key Symptoms: Sudden onset of intense hip pain Swelling and warmth in the affected hip joint Redness and tenderness around the joint Restricted movement or difficulty walking due to pain Potential fever in more severe cases
Diagnostic & Treatment
Diagnosis Path: The diagnosis of drug-induced gout of the hip involves a combination of medical history review, physical examination, and diagnostic tests. Key aspects include: - **Patient history**: Noting recent or ongoing use of medications associated with increased uric acid levels - **Joint examination**: Assessing inflammation and tenderness in the hip - **Blood tests**: Measuring serum uric acid levels, which are often elevated during a gout attack - **Joint aspiration**: Extracting synovial fluid from the hip to look for monosodium urate crystals under polarized light microscopy - **Imaging**: X-rays or ultrasound might be used to rule out other causes of joint pain or to detect joint damage caused by gout
Treatment Protocols: Managing drug-induced gout of the hip involves several strategies: - **Medication review and adjustment**: Discontinuing or changing medications that contribute to elevated uric acid levels under medical supervision - **Anti-inflammatory treatments**: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed to reduce pain and inflammation - **Colchicine**: May be used to control acute gout attacks - **Corticosteroids**: Administered orally or injected directly into the joint in severe cases - **Uric acid management**: Long-term therapies, such as allopurinol or febuxostat, to lower uric acid levels and prevent future attacks - **Lifestyle modifications**: Encouraging hydration, dietary adjustments to reduce purine-rich foods, and maintaining a healthy weight It’s essential for patients to work closely with their healthcare providers to tailor treatment plans, monitor progress, and minimize recurrence.
Clinical Advice & FAQs
Billing Guidance
Is M10.25 a billable ICD-10 code?
Yes, M10.25 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.25?
Clinical documentation must specify the nature of Drug-induced gout, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference